for the next generation of therapies

Expanding druggable space How we are expanding druggable space

PhoreMost is applying its proprietary SITESEEKER® technology to drive the discovery of tomorrow’s medicines

We are advancing a pipeline of novel targets in oncology and Targeted Protein Degradation (TPD)

View our pipeline View our pipeline and learn more about SITESEEKER®

We collaborate with a wide range of industry partners to develop ground-breaking medicines against challenging diseases

Partnering with us Find out more about partnering with us
Boehringer Ingelheim Otsuka Oxford Biomedica Roche Sentinel Oncologoy